Insider Transactions in Q1 2025 at Taysha Gene Therapies, Inc. (TSHA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2025
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
29,843
-2.35%
|
$29,843
$1.69 P/Share
|
|
Jan 02
2025
|
Sukumar Nagendran President and Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
324,500
+20.98%
|
-
|
|
Jan 02
2025
|
Sean P. Nolan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
892,500
+30.04%
|
-
|
|
Jan 02
2025
|
Kamran Alam CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
431,000
+25.31%
|
-
|